Whitehawk Therapeutics (WHWK) Other financing activities (2016 - 2025)
Whitehawk Therapeutics' (WHWK) quarterly Other financing activities came in at $2000.0 in Q3 2025, down 33.33% on a QoQ basis from $3000.0 in Q2 2025.
Whitehawk Therapeutics (WHWK) Other financing activities (2016 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 8 years of Other financing activities data on file, last reported at $2000.0 in Q3 2025.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $2000.0 in Q3 2025; TTM through Mar 2026 was $5000.0, a 76.19% decrease from a year earlier, with the FY2025 full-year figure at $26000.0, changed N/A from the prior year.
- Other financing activities for Q3 2025 stood at $2000.0, down from $3000.0 in the prior quarter.
- Over the last five years, Other financing activities for WHWK reached as high as $745000.0 in Q3 2021 and fell as low as -$745000.0 in Q4 2021.
- Historically, Other financing activities has averaged $31812.5 across 5 years, with a median of $35000.0 in 2023.
- On a YoY basis, Other financing activities climbed as much as 293.51% in 2022 and fell as far as 151.01% in 2022.
- Year by year, Other financing activities stood at -$745000.0 in 2021, then surged by 143.36% to $323000.0 in 2022, then slumped by 141.49% to -$134000.0 in 2023, then gained by 29.85% to -$94000.0 in 2024, then jumped by 102.13% to $2000.0 in 2025.
- Per Business Quant data, the three most recent Other financing activities figures were $2000.0 in Q3 2025, $3000.0 in Q2 2025, and $21000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Dec 31, 2023 | -134,000.00 |
| Dec 31, 2023 | -134,000.00 |
| Sep 30, 2023 | 245,000.00 |
| Sep 30, 2023 | 245,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Dec 31, 2022 | 323,000.00 |
| Dec 31, 2022 | 323,000.00 |
| Sep 30, 2022 | -380,000.00 |
| Sep 30, 2022 | -380,000.00 |